These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 10459126

  • 1. Adverse cutaneous reactions to ticlopidine in patients with coronary stents.
    Yosipovitch G, Rechavia E, Feinmesser M, David M.
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):473-6. PubMed ID: 10459126
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement.
    Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR.
    Circulation; 1999 Jan 19; 99(2):248-53. PubMed ID: 9892591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Frequency of adverse clinical events in the 12 months following successful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin).
    Berger PB, Bell MR, Grill DE, Melby S, Holmes DR.
    Am J Cardiol; 1998 Mar 15; 81(6):713-8. PubMed ID: 9527080
    [Abstract] [Full Text] [Related]

  • 5. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K, Wilensky RL, Julien MB, Herrmann HC, Spinler SA.
    Ann Pharmacother; 2006 Jun 15; 40(6):1204-7. PubMed ID: 16684808
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
    Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, Maida R, Collins M, Kreps E, Moses JW.
    Circulation; 1999 May 11; 99(18):2364-6. PubMed ID: 10318654
    [Abstract] [Full Text] [Related]

  • 7. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 11; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 8. Ticlopidine-induced neutropenia mimicking sepsis early after intracoronary stent placement.
    Ochoa AB, Wolfe M, Lewis P, Lenihan DJ.
    Clin Cardiol; 1998 Apr 11; 21(4):304-7. PubMed ID: 9562945
    [Abstract] [Full Text] [Related]

  • 9. Fixed drug eruption from ticlopidine, with positive lesional patch test.
    García CM, Carmena R, García R, Berges P, Camacho E, Cotter MP, de la Hoz B.
    Contact Dermatitis; 2001 Jan 11; 44(1):40-1. PubMed ID: 11156015
    [No Abstract] [Full Text] [Related]

  • 10. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.
    Tsui PT, Lai ST, Leung WS, Mok NS, Wu CW, Lau ST, Choi YC.
    Hong Kong Med J; 2002 Feb 11; 8(1):57-9. PubMed ID: 11861996
    [Abstract] [Full Text] [Related]

  • 11. Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues.
    Khambekar SK, Kovac J, Gershlick AH.
    Heart; 2004 Mar 11; 90(3):e14. PubMed ID: 14966075
    [Abstract] [Full Text] [Related]

  • 12. Clopidogrel-associated acute generalized exanthematous pustulosis.
    Ellerbroek JC, Cleveland MG.
    Cutis; 2011 Apr 11; 87(4):181-5. PubMed ID: 21644491
    [Abstract] [Full Text] [Related]

  • 13. Clopidogrel desensitization: case report and review of published protocols.
    Owen P, Garner J, Hergott L, Page RL.
    Pharmacotherapy; 2008 Feb 11; 28(2):259-70. PubMed ID: 18225971
    [Abstract] [Full Text] [Related]

  • 14. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW, Lee CW, Kim HS, Lee HJ, Park HK, Hong MK, Kim JJ, Park SJ.
    Am J Cardiol; 1999 Sep 01; 84(5):511-4. PubMed ID: 10482146
    [Abstract] [Full Text] [Related]

  • 15. Lichen planus-type drug eruption resulting from ticlopidine.
    Kurokawa I, Umehara M, Nishijima S.
    Int J Dermatol; 2005 May 01; 44(5):436-7. PubMed ID: 15869547
    [No Abstract] [Full Text] [Related]

  • 16. Ticlopidine-carbamazepine interaction in a coronary stent patient.
    Brown RI, Cooper TG.
    Can J Cardiol; 1997 Sep 01; 13(9):853-4. PubMed ID: 9343036
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y, Shim WH, Lee DH, Pyun WB, Kim IJ, Jang Y, Cho SY.
    Am J Cardiol; 1999 Dec 15; 84(12):1375-80. PubMed ID: 10606107
    [Abstract] [Full Text] [Related]

  • 18. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.
    Gawaz M, Seyfarth M, Müller I, Rüdiger S, Pogatsa-Murray G, Wolf B, Schömig A.
    Am J Cardiol; 2001 Feb 01; 87(3):332-6, A9. PubMed ID: 11165971
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population.
    Taniuchi M, Kurz HI, Lasala JM.
    Circulation; 2001 Jul 31; 104(5):539-43. PubMed ID: 11479250
    [Abstract] [Full Text] [Related]

  • 20. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
    Steinhubl SR, Tan WA, Foody JM, Topol EJ.
    JAMA; 1999 Mar 03; 281(9):806-10. PubMed ID: 10071001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.